| Reblozyl Celgene Corporation
2029544 10 Mar 2020 | on 19 Jan 2022 | Class 005 Class 005 Pharmaceutical Products Pharmaceutical preparations for use in the treatment of anemia, beta thalassemia, blood disease and cancer. | | | REBLOZYL CELGENE CORPORATION
1911773 26 Jul 2018 | on 15 Apr 2021 | Class 005 Class 005 Pharmaceutical Products Pharmaceutical preparations for use in the treatment of beta thalassemia and myelodysplastic syndromes, autoimmune disease, blood disease, cancer, arthritis in the fields of oncology, immunology and inflammation; pharmaceutical preparations, namely, cytokine inhibitory drugs; pharmaceutical preparations for the treatment of inflammatory diseases, namely, inflammatory bowel diseases, inflammatory connective tissue diseases; pharmaceutical preparations for the treatment of the musculoskeletal system, namely, connective tissue diseases, bone diseases, spinal diseases, back pain, fractures, sprains, cartilage injuries; pharmaceutical preparations for the treatment of bacterial skin infections, fungal skin infections, viral skin infections and parasitic skin infections; pharmaceutical preparations, namely, cytokine inhibitory drugs for use in the treatment of autoimmune diseases; pharmaceutical preparations, for the treatment of immunologic diseases, namely, autoimmune diseases, immunologic deficiency syndromes; blood tumors | | | REBLOZYL CELGENE CORPORATION
1822212 09 Feb 2017 | on 27 Jun 2019 | Class 005 Class 005 Pharmaceutical Products Pharmaceutical preparations for use in the treatment of beta thalassemia and myelodysplastic syndromes, autoimmune disease, blood disease, cancer, arthritis in the fields of oncology, immunology and inflammation; pharmaceutical preparations, namely, cytokine inhibitory drugs; pharmaceutical preparations for the treatment of inflammatory diseases, namely, inflammatory bowel diseases, inflammatory connective tissue diseases; pharmaceutical preparations for the treatment of the musculoskeletal system, namely, connective tissue diseases, bone diseases, spinal diseases, back pain, fractures, sprains, cartilage injuries; pharmaceutical preparations for the treatment of bacterial skin infections, fungal skin infections, viral skin infections and parasitic skin infections; pharmaceutical preparations, namely, cytokine inhibitory drugs for use in the treatment of autoimmune diseases; pharmaceutical preparations, for the treatment of immunologic diseases, namely, autoimmune diseases, immunologic deficiency syndromes; blood tumors | | | REBLOZYL & DESIGN CELGENE CORPORATION
2075384 06 Jan 2021 | on 05 Jan 2022 | Class 005 Class 005 Pharmaceutical Products Pharmaceutical preparations for use in the treatment of anemia, beta thalassemia, blood disease, cancer; | | | REBLOZYL & DESIGN IN BLACK & WHITE (VERSION 2) CELGENE CORPORATION
2285848 10 Oct 2023 | on 10 Oct 2023 | Class 005 Class 005 Pharmaceutical Products Pharmaceutical preparations for use in the treatment of anemia, beta thalassemia, blood disease, cancer. | | 
